<code id='59D1BB14E9'></code><style id='59D1BB14E9'></style>
    • <acronym id='59D1BB14E9'></acronym>
      <center id='59D1BB14E9'><center id='59D1BB14E9'><tfoot id='59D1BB14E9'></tfoot></center><abbr id='59D1BB14E9'><dir id='59D1BB14E9'><tfoot id='59D1BB14E9'></tfoot><noframes id='59D1BB14E9'>

    • <optgroup id='59D1BB14E9'><strike id='59D1BB14E9'><sup id='59D1BB14E9'></sup></strike><code id='59D1BB14E9'></code></optgroup>
        1. <b id='59D1BB14E9'><label id='59D1BB14E9'><select id='59D1BB14E9'><dt id='59D1BB14E9'><span id='59D1BB14E9'></span></dt></select></label></b><u id='59D1BB14E9'></u>
          <i id='59D1BB14E9'><strike id='59D1BB14E9'><tt id='59D1BB14E9'><pre id='59D1BB14E9'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:4952

          Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer drugs in particular has reached crisis levels.

          On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months. Oncologists are facing critical shortages of common, generic cancer medications and have even begun to ration care for certain patients who are able to delay treatment, according to Rice.

          advertisement

          “Patients are already under a lot of stress — they’re dealing with a cancer diagnosis, and they’re terrified. The last thing they want to hear is that something that’s critical to controlling their cancer might not be available, and we’re wondering where the next dose is going to come from,” Rice said.

          The conversation is based off Rice’s recent First Opinion, “Cancer drug shortages should have patients rioting in the streets.“

          Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

          comprehensive

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Biden's order seeks to regulate AI risk without stifling innovation
          Biden's order seeks to regulate AI risk without stifling innovation

          AdobePresidentBidenorderedthenation’sleadinghealthagenciesonMondaytodevelopaplanforregulatingartific

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Biogen’s boardroom scandal saddles CEO with first crisis

          ChrisViehbachertookoverasBiogenCEOinNovember.SuzanneKreiter/Globestaff;PhotoillustrationAlexHogan/ST